What is the recommended dose and duration of terbinafine (generic name: terbinafine) for a patient (pt) with chronic fungal infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The recommended dose of terbinafine for chronic fungal infections in adults is typically 250 mg once daily, with a treatment duration of 6 weeks for fingernail infections and 12-16 weeks for toenail infections, as supported by the British Association of Dermatologists' guidelines 1. The treatment duration may vary depending on the type of infection and the patient's response to therapy.

  • For fingernail infections, 6 weeks of treatment is generally recommended 1.
  • For toenail infections, 12-16 weeks of treatment is usually necessary 1. It is essential to note that terbinafine is generally preferred over itraconazole due to its higher efficacy and tolerability, as demonstrated in several large studies 1. Patients should be re-evaluated 3-6 months after treatment initiation, and further treatment should be given if the disease persists 1. Additionally, patients should be monitored for potential side effects, including liver function abnormalities, especially during extended treatment courses, and terbinafine may interact with certain medications like cimetidine and rifampin, so a medication review is important before starting therapy 1.

From the FDA Drug Label

Terbinafine tablets are an allylamine antifungal indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium) (1) Fingernail onychomycosis: One 250 mg tablet, once daily for 6 weeks. Toenail onychomycosis: One 250 mg tablet, once daily for 12 weeks

The recommended dose and duration of terbinafine for a patient with chronic fungal infection are as follows:

  • Fingernail onychomycosis: 250 mg once daily for 6 weeks.
  • Toenail onychomycosis: 250 mg once daily for 12 weeks. 2

From the Research

Recommended Dose and Duration of Terbinafine

The recommended dose and duration of terbinafine for a patient with chronic fungal infection vary depending on the specific condition being treated.

  • For onychomycosis, a dose of 250 mg daily for 12 weeks is recommended, with a 70% chance of cure 3.
  • For superficial dermatophytosis, a dose of 500 mg once daily for 2-6 weeks is effective, with 87-92% of patients showing a very good response 4.
  • For tinea pedis and tinea manuum, a 2-week treatment with 250 mg daily is successful, with 86% of patients becoming mycologically negative 5.

Treatment Duration

The duration of treatment with terbinafine also depends on the specific condition being treated.

  • For onychomycosis, a 4-month continuous course of terbinafine is more effective than a 3-month course, with a complete clinical and mycological cure rate of 78% 6.
  • For superficial dermatophytosis, treatment durations of 2-6 weeks are effective, with longer treatment durations resulting in higher cure rates 4.
  • For tinea pedis and tinea manuum, a 2-week treatment duration is sufficient, with 71% of patients judged to have received effective therapy 5.

Efficacy and Safety

Terbinafine is generally well-tolerated, with mild to moderate adverse effects reported in 5.3-12.9% of patients 7, 4.

  • The efficacy of terbinafine is high, with 70-92% of patients achieving a cure or very good response, depending on the specific condition being treated 3, 4, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.